These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3053309)

  • 1. Nuclear cardiology.
    Schad N
    G Ital Cardiol; 1988 Apr; 18(4):327-32. PubMed ID: 3053309
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty acid uptake and "metabolic imaging" of the heart.
    Klein MS; Sobel BE
    Cardiovasc Clin; 1979; 10(2):165-76. PubMed ID: 385142
    [No Abstract]   [Full Text] [Related]  

  • 3. [123I-metaiodobenzylguanidine myocardial images for assessment of sympathetic nervous system in the heart].
    Tanaka T; Aizawa T; Kato K
    Kokyu To Junkan; 1991 Aug; 39(8):755-66. PubMed ID: 1925097
    [No Abstract]   [Full Text] [Related]  

  • 4. Myocardial kinetics of 123I-labeled-16-hexadecanoic acid.
    Okada RD; Elmaleh D; Werre GS; Strauss HW
    Eur J Nucl Med; 1983; 8(5):211-7. PubMed ID: 6873097
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography as an aid in understanding electrocardiographic changes of ischemia, infarction, and cardiomyopathy.
    Grover-McKay M
    Ann N Y Acad Sci; 1990; 601():77-94. PubMed ID: 2221703
    [No Abstract]   [Full Text] [Related]  

  • 6. [123I-BMIPP-SPECT and myocardial metabolism].
    Naruse H; Iwasaki T; Fukuchi M
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):557-61. PubMed ID: 12436581
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-invasive analysis of metabolic reactions in body tissues, the case of myocardial fatty acids.
    Feinendegen LE; Vyska K; Freundlieb C; Höck A; Machulla HJ; Kloster G; Stöcklin G
    Eur J Nucl Med; 1981; 6(5):191-200. PubMed ID: 7250136
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of 123I-labeled p-phenylpentadecanoic acid (p-IPPA) for myocardial scintigraphy.
    Dudczak R; Schmoliner R; Kletter K; Frischauf H; Angelberger P
    J Nucl Med Allied Sci; 1983; 27(4):267-79. PubMed ID: 6674428
    [No Abstract]   [Full Text] [Related]  

  • 9. The Japanese experience with metabolic imaging in the clinical setting.
    Tamaki N; Morita K; Kawai Y
    J Nucl Cardiol; 2007; 14(3 Suppl):S145-52. PubMed ID: 17556183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Positron computed tomography of the heart].
    Yoshida K; Masuda Y; Yamazaki T; Tateno Y
    Kokyu To Junkan; 1984 Mar; 32(3):241-8. PubMed ID: 6610906
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial imaging and metabolic studies with [17-123I]iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy.
    Höck A; Freundlieb C; Vyska K; Lösse B; Erbel R; Feinendegen LE
    J Nucl Med; 1983 Jan; 24(1):22-8. PubMed ID: 6848699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications of radionuclide angiography versus contrast angiography in coronary heart disease.
    Schad N
    Ann Radiol (Paris); 1979 May; 22(4):272-3. PubMed ID: 496254
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity and accuracy of thallium-201 myocardial scintigraphy in the detection of coronary artery and myocardial disease (author's transl)].
    Lösse B; Krönert H; Rafflenbeul D; Feinendegen LE; Loogen F
    Z Kardiol; 1979 Jun; 68(6):429-35. PubMed ID: 463200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radioisotope studies].
    Schad N
    Cardiologia; 1987 Dec; 32(12):1697-700. PubMed ID: 3329028
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Nuclear Cardiology.
    Zaret BL; Battler A; Berger HJ; Bodenheimer MM; Borer JS; Brochier M; Hugenholtz PG; Neufeld HN; Pfisterer ME
    Circulation; 1984 Oct; 70(4):768A-781A. PubMed ID: 6335985
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP.
    Knapp FF; Franken P; Kropp J
    J Nucl Med; 1995 Jun; 36(6):1022-30. PubMed ID: 7769421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear cardiology (second of two parts).
    Berger HJ; Zaret BL
    N Engl J Med; 1981 Oct; 305(15):855-65. PubMed ID: 7024805
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myocardial scintigraphy with iodine 123-labeled fatty acids].
    Dudczak R
    Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of viable myocardium: current goal in ischemic heart disease with ventricular dysfunction].
    Marin-Neto JA; Bonow RO
    Arq Bras Cardiol; 1991 Jul; 57(1):1-3. PubMed ID: 1823754
    [No Abstract]   [Full Text] [Related]  

  • 20. The myocardial elimination rate of radioiodinated heptadecanoic acid.
    Visser FC; Westera G; van Eenige MJ; Van der Wall EE; Den Hollander W; Roos JP
    Eur J Nucl Med; 1985; 10(3-4):118-22. PubMed ID: 3996438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.